Customers

HELSINKI, FINLAND (March 07, 2022) - MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, by the University of Nebraska Medical Center (UNMC). UNMC scientists and clinicians are at the leading...

It’s a first in Switzerland: the Human Neuroscience Platform (HNP) will host a magnetoencephalography (MEG) facility next summer with the purchase of a MEGIN TRIUX™ neo, a state-of-the-art scanner that allows non-invasive analysis of brain activity. This acquisition is the result of a partnership between several institutions located at the Campus Biotech and promises new breakthroughs in the understanding and treatment of brain disorders such as Alzheimer’s, epilepsy or aphasia.

HELSINKI, FINLAND (January 27, 2022) - MEGIN is pleased to announce the sale of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, to the Norman Fixel Institute for Neurological Diseases at University of Florida Health (UF Health). The...

MEGIN is delighted to be joining the Association of British HealthTech Industries (ABHI) UK Pavilion at Arab Health 2022, which is taking place from 24- 27 January in Dubai. The exhibition – the largest event of its kind in the Middle East – will showcase more than...

In this article, Professor Stefano Seri, Consultant Clinical neurophysiologist of the Epilepsy Surgery programme at Birmingham Children’s Hospital provides a contemporary look at how the imaging modality is optimizing diagnosis and changing paediatric and adult post-surgery outcomes for the better.

HELSINKI, FINLAND (June 1, 2021) – MEGIN is pleased to announce the acquisition of a TRIUX™ neo by The Centre For Cognitive Neuroimaging (CCNi), at the Institute for Neuroscience and Psychology at the University of Glasgow. This research facility will continue its...

HELSINKI, FINLAND (March 4, 2021) – MEGIN is delighted to support Boys Town National Research Hospital® in Nebraska in their journey to revolutionize child and teen brain research at the new Institute for Human Neuroscience. The Institute will be a brand-new 15,000+...

  HELSINKI, FINLAND (November 26, 2020) – MEGIN is delighted to be partnering with Spectrum Health's Helen DeVos Children’s Hospital in Grand Rapids, Michigan, by delivering our fourth-generation technology, the TRIUX™ neo. We are excited to expand the access of...

HELSINKI, FINLAND (October 1st, 2020) – MEGIN is delighted to announce the sale of our fourth-generation technology, the TRIUX™ neo, to The Institute for Learning & Brain Sciences (I-LABS) of the University of Washington, USA. I-LABS is an interdisciplinary center...

Welcome to MEGIN Community!Starting at the end of 2020, MEGIN Community will be available to TRIUX™ neo customers.Coming soon...  Watch and learn Fresh online training courses How can we help you? Contact MEGIN Customer Care Have a question? Need more information?...

HELSINKI, FINLAND (August 05, 2020) – MEGIN is pleased to announce the sale of our Internal Helium Recycler (IHR) to Swinburne University of Technology. Based in Melbourne Australia, Swinburne is a world-class university creating social and economic impacts through...

HELSINKI, FINLAND (JULY 7, 2020) – MEGIN is pleased to announce the sale of our fourth-generation technology, the TRIUX™ neo, to Amsterdam UMC, location VU University Medical Center (VUmc). VUmc is one of the largest care and research institutions in the Netherlands...